Indicators

Latest News about LEXX

Recent news which mentions LEXX

< Previous 1 2 3 4 Next >

Why Is Lexaria Bioscience (LEXX) Stock Up Today?

April 14, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

April 14, 2022

Why Lexaria Shares Are Rising Today

April 14, 2022

Lexaria Bioscience (NASDAQ: LEXX) Issues Update On Human Nicotine Study

April 13, 2022

Lexaria Bioscience (NASDAQ: LEXX) Begins Nicotine Formulation Creation, Evaluation Program

April 12, 2022

Lexaria Aims To Demonstrate DehydraTECH's Performance In Epilepsy Research

April 11, 2022

Lexaria Bioscience's 24th Patent Sets Stage For Market Opportunities In Australia

March 31, 2022

Lexaria Bioscience Optimistic About Upcoming Hypertension Study

March 28, 2022

Lexaria's IP Portfolio Grows Following Receipt Of 24th Granted Patent

March 22, 2022

Lexaria Bioscience Commences DehydraTECH-CBD Epilepsy Research Program

March 16, 2022

Lexaria Bioscience Receives Award For Oral Nicotine Compound Patent

March 09, 2022

Studies Advance Lexaria Bioscience's Tech For Improving Pharmaceutical Drugs

March 07, 2022

Lexaria's DehydraTECH(TM) Demonstrates Faster Delivery Of Sildenafil

March 04, 2022

Lexaria Bioscience Optimistic Of Positive Study Results

February 28, 2022

Lexaria Optimistic About Expanded DehydraTECH Investigations

February 23, 2022

Lexaria World Leader Through DehydraTECH(TM) – Its Pioneering Drug Delivery Tech

February 22, 2022

Following Sildenafil Study, Lexaria Announces Plans For More Studies In 2022

February 17, 2022

Lexaria's DehydraTECH(TM) To Be Evaluated As Treatment For Multiple Conditions

February 14, 2022

Lexaria Technology Shows Promise In Improving Performance Of ED Drugs

February 11, 2022

Lexaria CEO Summarizes 2021 Milestones in Letter to Shareholders

February 09, 2022

Lexaria Bioscience Announces Significant Findings From Sildenafil Animal Study

February 03, 2022

Lexaria CEO Offers A Glimpse Into Company's Unique Tech On EDGE Podcast

February 01, 2022

Lexaria Emphasizes Oral Cannabinoid Benefits Following SARS-CoV-2 Study

January 28, 2022

Lexaria Bioscience Marks Great Start to its 2022 R&D Programs

January 21, 2022

Lexaria Bioscience Comments on Study Examining Cannabinoids and SARS-CoV-2

January 19, 2022

Lexaria Bioscience Leveraging DehydraTECH(TM) for More Effective Oral Medicine

January 18, 2022

Lexaria Bioscience Celebrates Productive Year for Blood Pressure Drug Solution

January 12, 2022

Lexaria Bioscience (NASDAQ: LEXX) Receives Independent Review Board Approval for Human Study

January 11, 2022

12 Health Care Stocks Moving In Friday's After-Market Session

January 07, 2022

Lexaria Bioscience Increases Investor Visibility with SRAX

January 07, 2022

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.